| 注册
首页|期刊导航|肿瘤学创新(英文)|Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer(2025 Edition)

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer(2025 Edition)

Fei Ma Binghe Xu

肿瘤学创新(英文)2025,Vol.4Issue(3):54-78,25.
肿瘤学创新(英文)2025,Vol.4Issue(3):54-78,25.DOI:10.1002/cai2.70008

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer(2025 Edition)

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer(2025 Edition)

Fei Ma 1Binghe Xu1

作者信息

  • 折叠

摘要

关键词

AKT inhibitor/breast cancer/expert consensus/hormone receptor/mTOR inhibitor/PI3K inhibitor

Key words

AKT inhibitor/breast cancer/expert consensus/hormone receptor/mTOR inhibitor/PI3K inhibitor

引用本文复制引用

Fei Ma,Binghe Xu..Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer(2025 Edition)[J].肿瘤学创新(英文),2025,4(3):54-78,25.

基金项目

This study was funded by the Major Collaborative Innovation Project,Medical and Health Science and Technology Innovation Initiative,Chinese Academy of Medical Sciences(Project No.2021-I2M-1-014). (Project No.2021-I2M-1-014)

肿瘤学创新(英文)

2770-9183

访问量1
|
下载量0
段落导航相关论文